Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
This protocol will investigate whether topical application of N-acetyl cysteine (NAC) eye
drops decreases oxidative stress and confers cytoprotection in patients with FECD.